Renowned Urologic Oncology Leader Dr. Murugesan Manoharan Delivers Keynote Address at BAUS
Dr. Murugesan Manoharan, Chair of Urology at Miami Cancer Institute, delivered a keynote at the BAUS Annual Meeting, addressing PSA screening, early detection, and evolving surgical strategies.
Murugesan Manoharan, Chair of Urology at Miami Cancer Institute and the Abbhi Family Endowed Chair in Urologic Oncology, recently delivered a keynote lecture at the British Association of Urological Surgeons (BAUS) Annual Meeting.
Recognized internationally as a leader in robotic urologic oncology, bladder cancer surgery, and prostate cancer management, Dr. Manoharan discussed contemporary approaches to PSA screening, early cancer detection, and evolving surgical strategies for urologic malignancies. Baptist Health notes his extensive leadership in robotic urologic surgery, bladder cancer research, and multidisciplinary cancer care.
His participation at one of the world's most prestigious urological meetings further highlights Miami Cancer Institute's growing influence in global urologic oncology education and research.
